These findings seem to be consistent with a recent study showing that, in the context of NASH, CD4+ lymphocytes seem to be more susceptible to fatty acid-induced ROS cytotoxicity [29]. The gene discussed is CD4; the disease is metabolic dysfunction-associated steatohepatitis.